Cigna (CI) Stock Price, Fundamentals & Analysis

What CI does

Cigna (CI) is a US stock in the Healthcare sector, specifically the Healthcare Plans industry, headquartered in Bloomfield, United States. The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services, which includes pharmacy benefit management and specialty pharmaceutical distribution, and Cigna Healthcare, which delivers employer medical plans, individual and family plans, behavioral health, dental, and global health care solutions. The company is part of the S&P 500.

Key numbers explained

• 268.27 USD is the current share price, representing the last traded value in USD.
• The trailing P/E ratio of 11.1 compares the share price to the last 12 months of earnings per share (24.17 USD), a common way to gauge how much investors pay for each dollar of earnings.
• The forward P/E ratio of 8 uses expected future earnings, often viewed as a more optimistic valuation measure.
• The dividend yield of 2.28% shows the annual dividend as a percentage of the share price; the exDividendDate is 8 sept. 2026.
• 25% of earnings are paid out as dividends, indicating the portion of profit returned to shareholders.
• Beta of 0.32 suggests the stock has historically been less volatile than the overall market.
• The 52-week price range is 239.51 – 315.47, with the current price near the lower end of that range.
• The debt-to-equity ratio of 74.3% measures financial leverage, showing how much debt the company uses relative to shareholder equity.

Recent news

Recent headlines highlight discussions around health-sharing models, comparisons with UnitedHealth, and the potential role of artificial intelligence in managing healthcare costs. One title questions whether UnitedHealth identified a fix before its stock moved, while another asks whether Cigna's AI efforts can help control rising costs. The titles also reference margin analysis for Aetna and CVS, as well as a cost line that UnitedHealth has not yet addressed.

What to watch

Investors typically monitor healthcare policy changes, regulatory decisions on drug pricing, and broader insurance enrollment trends. For peers, tracking companies like Henry Schein (HSIC), Cencora (COR), and Incyte (INCY) can provide context on sector dynamics. Earnings reports, especially the next one on 5 nov. 2026, often drive short-term price movements.